Publications en collaboration avec des chercheurs de Brigham and Women's Hospital (24)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2017

  1. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2014

  1. Coinhibitory suppression of t cell activation by CD40 protects against obesity and adipose tissue inflammation in mice

    Circulation, Vol. 129, Núm. 23, pp. 2414-2425

2012

  1. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD

    Respiratory Research, Vol. 13

2011

  1. Gender differences in plasma biomarker levels in a cohort of COPD patients: A pilot study

    PLoS ONE, Vol. 6, Núm. 1

  2. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells

    Molecular Cancer Research, Vol. 9, Núm. 8, pp. 1139-1151

2010

  1. CD40L induces inflammation and adipogenesis in adipose cells - A potential link between metabolic and cardiovascular disease

    Thrombosis and Haemostasis, Vol. 103, Núm. 4, pp. 788-796

  2. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall

    Circulation, Vol. 121, Núm. 18, pp. 2033-2044

2006

  1. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis

    Journal of the American College of Cardiology, Vol. 47, Núm. 7, pp. 1369-1378

  2. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk

    American Heart Journal, Vol. 151, Núm. 2, pp. 367.e7-367.e16

  3. Family History of Diabetes Is a Major Determinant of Endothelial Function

    Journal of the American College of Cardiology, Vol. 47, Núm. 12, pp. 2456-2461

  4. Influence of pre-analytical and analytical factors on soluble CD40L measurements

    Clinical Science, Vol. 111, Núm. 5, pp. 341-347

2005

  1. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: Results from the Dallas Heart Study

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 10, pp. 2192-2196

  2. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products

    Diabetes and Vascular Disease Research, Vol. 2, Núm. 2, pp. 81-87

2004

  1. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques

    Circulation, Vol. 110, Núm. 14, pp. 1953-1959

2003

  1. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones

    Circulation, Vol. 107, Núm. 21, pp. 2664-2669

  2. Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

    Arteriosclerosis, Thrombosis, and Vascular Biology